Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas

Neurology

Volumn 44, Issue 8, 1994, Pages 1479-1483

  Garfield, J ^a   McDonald, H ^a   Punt, J ^b   Sokal, M ^b   De Tribolet, N ^c   Regli, L ^c   Favre, J ^c   Vernet, O ^c   Darcel Menault, F ^d   Ben Hassel, M ^d   Guegan, Y ^d   Afra, D ^e   Kocsis, B ^e   Mayer, A ^e   Sipos, L ^e   Hildebrand, J ^f   Brotchi, J ^f   Dewitte, O ^f   Regnier, R ^g   Chatel, M ^h   Frenay, M ^h   Hery, M ^h   Maat, B ⁱ   Haferkamp, G ^j   Karstens, J H ^j   Samii, M ^j   Dietz, H ^j   Brucher, J M ^k   Sahmoud, T ^l   Mignolet, F ^l   more..

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d RENNES UNIVERSITY HOSPITAL   (France)

^e NATIONAL INSTITUTE OF NEUROSURGERY   (Hungary)

^f ERASME HOSPITAL   (Belgium)

^g JULES BORDET INSTITUTE   (Belgium)

^h UNIVERSITY HOSPITAL OF NICE   (France)

ⁱ DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

^j Henriettenstiftung   (Germany)

^k UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^l NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

LOMUSTINE; MITOLACTOL;

ADULT; AGED; ARTICLE; BRAIN RADIATION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; CHEMOTHERAPY, ADJUVANT; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; MITOLACTOL; SURVIVAL ANALYSIS;

EID: 0028107037     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.44.8.1479     Document Type: Article

References (26)

1. Hildebrand J. Treatment of primary brain tumours. In: Hildebrand J, ed. Management in neuro-oncology. Berlin: Springer-Verlag, 1992:3-22.
2. Walker MD, Alexander E Jr, Hunt WE, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: a cooperative clinical trial. J Neurosurg 1978;49: 333-343.
3. Walker MD, Green SB, Byar DP, et al. Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med 1980;303: 1323-1329.
4. Afra D, Kocsis B, Dobay J, Eckhardt S. Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in postoperative treatment of malignant gliomas. J Neurosurg 1983;59:106-110.
5. Afra D, Kocsis B, Kerpel-Fronius S, Eckhardt S. Dibromo-dulcitol-based combined postoperative chemotherapy of malignant astrocytomas and glioblastomas. J Neurooncol 1986;4:65-70.
6. Levin VA, Silver P, Hannigan J, et al. Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 1990;18:321-324.
7. EORTC Brain Tumor Group. Effect of CCNU on survival, rate of objective remission and duration of free interval in patients with malignant brain glioma—first evaluation. Eur J Cancer 1976;12:41-45.
8. EORTC Brain Tumor Group. Evaluation of CCNU, VM-26 plus CCNU and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. J Neurosurg 1981;55:27-31.
9. EORTC Brain Tumor Group. Misonidazole in radiotherapy of supratentorial malignant gliomas in adult patients: a randomized double-blind study. Eur J Cancer Clin Oncol 1983;19:39-42.
10. EORTC Brain Tumor Group. Cisplatin does not enhance the effect of radiation therapy in malignant gliomas. Eur J Cancer 1991;27:568-571.
11. Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trials. Biometrics 1975;31:103-115.
12. Dupont WD, Plummer WD. Power and sample size calculations: a review and a computer program. Controlled Clin Trials 1990;11:116-128.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemo-ther Rep 1966;50:163-170.
15. Cox DR. Regression models and life-tables. J R Stat Soc 1972;B34:187-202.
16. Sposto R, Ertel IJ, Jenkin RDT, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 1989;7:165-177.
17. Shapiro WR, Green SB, Burger PC, et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. J Neurosurg 1989; 71:1-9.
18. Fine HA, Dear KBG, Loeffler JS, Black PMcL, Canellos GP. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 1993;71:2585-2597.
19. Horvath IP, Kralovansky J, Elekes I, et al. Studies on the mechanism of action of cytostatic hexitol derivatives. Proc Int Congr Chemother 1972;2:27-29.
20. Institoris L, Horvath IP, Pethes G. Some characteristic features of the biotransport of the cytostatic agent 1,6-dibromo-1,6-di-deoxy-dulcitol. Int J Cancer 1967;2:21-25.
21. Hidvegi EJ, Lonai P, Holland J, et al. The effect of mannitol-myleran and two new dibromo-hexitols on the metabolic activities of nucleic acids and proteins. I. Biochem Pharmacol 1967;16:2143-2153.
22. Pulst SM, Deen DF. Potentiation of BCNU-induced cytotoxicity and sister chromatid exchanges by dibromodulcitol in vitro. Anticancer Res 1990;10:1647-1650.
23. Hidvegi EJ, Perlaky A, Fonagy L, et al. Combination of dibromodulcitol with X-irradiation increases the life span of mice bearing experimental brain tumours [abstract]. In: 14th International Cancer Congress, Budapest, Hungary: Abstracts, vol 1. Budapest: Akademiai Kiado, 1986:47.
24. Eckhardt S. Ten-year international clinical experience with DBD in the treatment of malignant diseases. In: Eckhardt S, ed. Dibromodulcitol. Budapest: Medicina Konyvkiado, 1982:174-190.
25. Kelley SL, Peters WP, Andersen J, Furlong EA, Frei E, Hen-ner WD. Pharmacokinetics of dibromodulcitol in humans: a phase I study. J Clin Oncol 1986;4:753-761.
26. Afra D, Mayer A, Sipos L. Multimodality treatment of anaplastic supratentorial gliomas with high-dose dibromodulcitol and dibromodulcitol plus BCNU. A pilot study. Clin Neurosci Ideggy Szle 1993;46:420-424.